Delivery Order SPE2DB24D2102-SPE2DB25FJJLV
- Not listed
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Vyndamax 61 mg capsules in unit-dose packaging (30-count). The contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This competitively...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. The contract utilizes firm fixed pricing with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This...
- The Defense Logistics Agency awarded a $27,693.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. This non-set-aside award was competitively procured and is scheduled for completion by August 12, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete task order issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Vyndamax 61 mg capsules. The $24,690.70 contract has a completion date of February 7, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a leading global pharmaceutical sourcing and distribution services company that has received numerous federal contract awards to supply pharmaceuticals, medical supplies, and...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packages) with an ultimate completion date of August 8, 2025. The contract, issued on July 18, 2025, is unclassified and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for VYNDAMAX 61 mg capsule unit dose packaging (30-count) on July 28, 2025, with completion scheduled for August 18, 2025. This competitively awarded, firm fixed price delivery order represents a child contract against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30, with a ceiling value of $13,846.97. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award criteria. The contract is set to complete by August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyndamax (tafamidis) is a...
- This federal contract award, valued at $13,846.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vyndamax 61 mg capsules over a period ending on May 23, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $24,690.70 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to supply 61 mg Vyndamax capsules. Performance will take place in Conshohocken, Pennsylvania over a period of approximately one month, from September 22nd through October 16th, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the United...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twelve thousand three hundred forty-five dollars and thirty-four cents to Amerisourcebergen Drug Corporation for the supply of Vyndamax 61 mg capsules. Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements between September 12, 2023 and October 3, 2023. As a major distributor of pharmaceuticals and medical supplies...
- SPE2DB24D2102Indefinite Delivery Contract
- SPE2DB24D2102-SPE2DB25FJJLVDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,846.97 on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a completion deadline of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle that extends through December 2026 and serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards through the Defense Logistics Agency's Medical Supply Chain, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's consistent success in competitively awarded delivery orders demonstrates its capability to meet federal procurement standards. This particular delivery order for Vyndamax—a medication used to treat transthyretin cardiac amyloidosis—supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems in meeting pharmaceutical supply requirements for military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 7/28/25 |